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Abstract
Patient: A case of Turner’s syndrome developing a leiomyosarcoma of the oropharynx and metachronous neurogenic
tumors (mediastinal ‘ganglioneuroblastoma intermixed’, subcutaneous neurilemoma) is described.
Discussion: To our knowledge, this case is the second reported leiomyosarcoma in a patient with Turner’s syndrome. Also
the site of involvement (palate and oropharynx) is particularly unusual for the already rare leiomyosarcomas in the young age.
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Introduction
The occurrence of gonadal tumors in gonadal dys-
genesis is a  well known phenomenon.1–3 A higher
incidence of extragonadal neoplasms with a prepon-
derance of neurogenic tumors is also reported, sug-
gesting  that  developmental  neural  defects,
hamartomatous growths, and susceptibility to neuro-
genic tumors are related to one another as an expres-
sion of Turner’s phenotype.4 A few example of soft
tissue  sarcomas  are  also  reported5–8  but  to  our
knowledge  only  one  leiomyosarcoma  (LMS)  has
already been described in this setting.9 On the other
hand, leiomyosarcoma is  a  rare  tumor  in children
and  adolescents.10,11  The  visceral  ones  are  often
related to genetic12  or acquired immunodeficiency
disorders,13–15  or immunosuppressive drugs16  and
arise in the hepatobiliary, gastrointestinal, and tra-
cheopulmonary  systems.  In  most  cases  they  were
shown  to  be  associated  with  Epstein-Barr  virus
(EBV).17
We  describe  a  leiomyosarcoma  occurring  in  a
patient with Turner’s syndrome and metachronous
neurogenic tumors  (mediastinal  ‘ganglioneuroblas-
toma intermixed’, subcutaneous neurilemoma). Also
the  site of involvement (palate  and oropharynx) is
particularly unusual for the already rare leiomyosar-
comas at a young age.
Clinical history
The patient was diagnosed with Turner’s syndrome a
few months after birth. For this reason, she had estro-
gen  replacement therapy  for  the  last  7  years.  She
underwent to thoracotomy because of a mediastinal
‘ganglioneuroblastoma  intermixed’  (Shimada:
schwannian stroma-rich) (Fig. 1) when she was 4-
year-old. She was treated with radiotherapy and she
was well and free of disease for 18 years.
Fig. 1. Mediastinal ‘ganglioneuroblastoma intermixed’. In a 
stromal-rich background, microscopic foci of differentiating neu-
roblasts and more or less mature ganglion cells are interspersed. 
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At the age of 22, she was referred to our hospital
with a huge tumor, more than 10 cm. in largest diam-
eter, infiltrating the whole soft palate, the ventral side
of the posterior hard palate, the right tonsillar pillar
and deeply into the parapharyngeal space and retro-
molar trigone on the right side (Fig. 2). An incisional
biopsy showed spindle and rounded cells with often
vacuolar or clear cell change in the cytoplasm (Fig.
3), strongly positive to muscle specific actin (MSA)
(Fig. 4) and to desmin (Fig. 5), with the diagnosis of
epithelioid leiomyosarcoma G3. At the same time,
two cutaneous nodules (left and right thigh) of 1.5
cm. in largest diameter and a subcutaneous lesion of
2 cm. (in the right axilla) were noted and excised. The
cutaneous nodules proved to be sclerotic dermatofi-
bromas with some large atypical mesenchymal cells;
the subcutaneous one was a neurilemoma. Serological
tests for HBV, HCV, HIV and EBV were negative.
The cytogenetic analysis performed on tissue from
the  neurilemoma  by  standard  cytogenetic  method
showed the expected monosomy of chromosome X
and chromosome aberrations with a complex karyo-
type (Fig. 6A). FISH analysis revealed that the most
Fig. 2. CT scan sections through the oral cavity show a large 
mass in the oropharynx infiltrating soft palate with ventral inva-
sion of the posterior edge of the hard palate.
Fig. 3. Epithelioid leiomyosarcoma of the oropharinx. Pleomor-
phic round to spindle cells with clear or vacuolar cytoplasm and 
with atypical mitoses are present beneath the oral mucosae. 
(H&E 3 20)
Fig. 4. MSA is strongly positive in the neoplastic cells. (immu-
noperoxidase 3 20)
Fig. 5. Desmin is strongly positive in the neoplastic cells. 
(immunoperoxidase 3 20)
Fig. 6. A) G-banded karyotype of a cell from the neurilemoma 
shows multiple abnormalities and structural rearrangements such 
as del(1)(p), del (6)(q22), del (8)(p), der(12)dup(q13–22), 
loss of a chromosome 13, 14, 19 and X, other unknown rear-
rangemets defined as markers which probably are derived from 
chromosome 3, 7, 8, 12 and 18. B) FISH with Chromophobe 
Multiprobe (Cy 3). Chromosome 6 hybridization: the small spot 
indicates a rearranged chromosome 6.Leiomyosarcoma in Turner’s syndrome 153
frequent abnormalities were loss of chromosomes 13,
14 and 22, deletions [such as del(1)(p), del (6)(q22)]
and  rearrangements [such as  der(12)dup(q13–22),
t(7;9)(q11;q11),  t(6;?)]  (Fig.  6B).  FISH  revealed
also the presence of part of the Y chromosome trans-
located on a chromosome of the D group in 10% of
the metaphases.
Because  of  the  site  and  size  of  the  lesion,  the
patient was treated by chemotherapy (epirubicin 80
mg/m,2 ifosfamide 7.5 gr/m,2 DTIC 900  mg/m2,),
but after two courses she developed a 2.5 cm. right
retromandibular lymph  node  metastases  while  the
oropharyngeal  mass  was  unmodified by  CT  scan.
Then she went to a full course of radiation therapy.
The Target Volume included the whole palate, the
oropharynx and the lymph nodes of the left neck. A
total dose of 66 Gy (2 Gy/fraction) was delivered in
64 days using two lateral portals with 6 MV photons
to  gross tremor  volume (GTV)  and bilateral  neck
lymph  nodes,  and  two  opposed  antero-posterior
fields for supraclavicular nodes for a total dose of 50
Gy. Radiation therapy was stopped on two occasions
(a  week  each  time)  because  of  severe  laryngeal
mucositis. Seventy-five days from the end of radio-
therapy, the MRI showed a significant reduction in
the  tumor mass with  fairly  good  clinical improve-
ment. But a month later, she developed local progres-
sion and then lung metastases. She died after a month
from respiratory failure.
Discussion
Leiomyosarcoma is a rare tumor in children and ado-
lescents.10,11 However, at least some cases reported
as LMS, especially those diagnosed in neonates, may
represent  examples  of  congenital-infantile  myofi-
bromatosis  with  an  excellent  prognosis.18  Some
authors also propose that some tumors present in the
bronchopulmonary tree, particularly when in endo-
bronchial location, are more often misdiagnosed as
LMS while  in fact  are  better  regarded as  primary
bronchopulmonary fibrosarcoma.  These  histotypes
have a relatively good outlook, representing the bron-
chopulmonary counterpart of the congenital-infantile
myofibromatosis of the soft tissue.19 A recent review
of 20 childhood LMSs shows that they have a rela-
tively good prognosis in the majority of the cases and
the occurrence of this neoplasm in the oral cavity is
exceedingly rare, as already reported.18,20 While lei-
omyosarcomas account for about 1% of all soft tissue
tumors in childhood (18, also personal experience of
one of us, V.N.), they are the second most frequent
malignancy in children with acquired immunodefi-
ciency syndrome (AIDS).15 In this cohort they are
often located in unusual sites especially visceral ones
such as hepatobiliary, gastrointestinal, and tracheop-
ulmonary systems.14  Based  on the  reported cases,
EBV  seems  to  be  involved  in  the  pathogenesis of
these tumors in immunosuppressed patients, while
there is no evidence of its presence in the LMS in
immunocompetent patients.17 Thus the oncogenesis
of these neoplasms seems to be different in the two
subgroups of patients.
Individuals with a history of childhood cancer have
been estimated to have 10 to 20 times the lifetime risk
of a second cancer compared with age-matched con-
trols. Within the first 20 years after the initial diagno-
sis, the incidence appears to be on the order of 3% to
12%.21  In  most  cases,  the  second  malignancy  is
related to ionizing radiation or aggressive chemother-
apy, especially alkylating agents. The two main crite-
ria to classify a sarcoma as radiation induced are: 1)
the patient should be have been irradiated for another
malignancy at least 3 years prior to sarcoma diagno-
sis, and 2) the sarcoma should have developed within
the field of radiation. In our case, the patient received
radiation for a mediastinal tumor, but the oropharyn-
geal sarcoma she developed after 18 years was clearly
outside  of  the  prior  radiation  field.  She  had  not
received any chemotherapy for the ganglioneuroblas-
toma.  Therefore,  we  concluded  that  the  second
tumor had no links to the therapy.
Alternatively, it is postulated that the occurrence of
second cancers may be related to the presence either
of an underlying systemic disease (such as von Reck-
linghausen’s neurofibromatosis) or of chromosomal
abnormalities  shared  by  multiple  organs  in  which
they are tumorigenic such as occurs in some congen-
ital tumors or in Li-Fraumeni syndrome. Thus the
simultaneous or sequential appearance of  different
tumors within an individual may be the clue to their
shared genetic etiology. It appears that the majority of
hereditary  cancer  predisposition  is  attributable  to
germline mutation in tumor suppressor genes now
known to be critically important in growth control of
both sporadic and hereditary tumors. Mapping and
cloning of the retinoblastoma gene proved Knudson
‘two-hits’  hypothesis  and  elucidated the  nature  of
tumor suppressor genes.22
The  increased risk for  malignant  transformation
within  dysgenetic gonads has  been documented in
numerous  reports,  most  of  which  occurred  in
Turner’s syndrome with 45,X karyotype or in a phe-
notypic female with Y chromosome.2 The most fre-
quent  types  of  tumors  in  this  setting  are
gonadoblastoma and dysgerminoma.1,3 Non gonadal
malignancies are also reported with a preponderance
of melanocytic nevi and peripheral neurogenic neo-
plasms, both neural crest derivates, among children
and young adults.4 In these cases, it has been postu-
lated that these syndromes may have a mechanism of
tumor susceptibility such as occurs in the neurocuta-
neous disorders, particularly neurofibromatosis type
I, in which the NF1 gene is homozygously inactivated
in both benign and malignant tumors related to it,
and  nevoid  basal  cell  carcinoma  syndrome
(NBCC).22 So Turner’s syndrome may be added to
those congenital disorders in which aberrant develop-154 A. De Chiara et al.
ment of neural-crest derivates predisposes to neopla-
sia.4  We  have  to  underline  that  our  patient  was
affected by Turner’s syndrome, cytogenetically diag-
nosed  a  few  months  after  birth.  She  presented  a
mediastinal ‘ganglioneuroblastoma intermixed’ (Shi-
mada: schwannian stroma-rich) at the age of 4 years,
and later in life a subcutaneous neurilemoma in the
right axilla and two sclerotic dermatofibromas in the
left and the right thigh.
Some childhood solid tumors occur in close asso-
ciation with hereditary syndromes. For example, soft
tissue  sarcomas  especially  rhabdomyosarcoma
(RMS), osteosarcoma, brain tumors are frequent in
families affected by the Li-Fraumeni syndrome. Sur-
vivors  of  hereditary  retinoblastoma,  are  prone  to
develop later in life osteosarcomas of bone and soft
tissue sarcomas, mainly RMS and fibrosarcoma. In
addition, children with neurofibromatosis type I are
at increased risk to develop soft tissue malignancies
such  as  malignant  peripheral  nerve  sheath  tumors
(MPNST), RMS and angiosarcoma.22 Instead, the
occurrence of sarcomas in Turner’s syndrome is a
very rare event with only few published cases.4–9 For
the endometrial sarcomas, as already postulated for
endometrial carcinomas,23,24 it has been suggested
that the risk may be increased by estrogen replace-
ment therapy or endogenous disorders that lead to
unopposed estrogenic stimulation of  the  uterus.6,7
This mechanism has also been recalled for LMS of
the  uterus25  and  oral  cavity26  of  patients  without
Turner’s  syndrome.  Experimental  studies  showed
that treatment with testosterone propionate (TP) and
dyethylstilbestrol (DES) or TP and estradiol (E2) for
8–9 months causes LMS in vas deferens or uterus of
Golden Syrian hamsters at a frequency of 100%. The
authors hypothesize that treatment with TP and E2
causes a  loss of the  protective  enzyme hGSTYBX
leaving the cells vulnerable to the genotoxic effects of
estrogen or estrogenic metabolities.27
LMS with clonal abnormalities display highly com-
plex karyotypic changes and extensive heterogeneity,
suggesting that the karyotypic profile is more depen-
dent on site of origin than on microscopic features.28
In our case,  the  cytogenetic analysis  was  done on
tissue  from  the  subcutaneous  neurilemoma  that
showed a very complex picture with many different
rearrangements and deletions. Literature reports that
loss of chromosome 22 is frequent in neurilemoma
and  also  the  monosomy  of  chromosome  14  was
sometimes observed.29,30 But the other abnormali-
ties, such as the complex rearrangements involving
chromosomes 9  and  12,  and  the  large  number of
chromosome aberrations resemble more closely the
karyotypic changes observed in sarcomas28 than to
the changes described so far in neurilemomas.
To our knowledge, this case is the second reported
leiomyosarcoma  in  a  patient  with  Turner’s  syn-
drome,  which  was  also  affected  by  metachronous
neurogenic tumors. The site of involvement (palate
and oropharynx) is unusual for the already rare lei-
omyosarcomas in the young age.
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